These results indicate that upregulated DNMT mRNA expression may not be sufficient to suppress RASSF10 expression in HCC, and additional strategies, such as viral infection to alter demethylase activity, may be necessary to specify the targeted cytosine residue for methylation [30, 33, 34]. This evidence concerns the gene MBD2 and hepatocellular carcinoma.